Irena Melnikova, Ph.D.

Chief Financial Officer

Irena Melnikova joined Umoja Biopharma as Chief Financial Officer in May 2021, bringing with her 20 years of experience in equity financing in both private and public markets, corporate strategy, business development and operations. Prior to Umoja, Irena served as a Managing Director in Investment Banking at SVB Leerink, where she provided critical advice to biopharma companies on equity financing strategies, completing over 80 transactions. Prior to SVB Leerink, Irena was a Managing Director at Burrill & Company and, prior to that, Director of Strategy and External Innovation at Sanofi where she led efforts to identify and initiate partnership opportunities with companies in the northeastern United States. Irena has also held leadership positions at TVM Capital, a global life sciences venture capital firm, investing in biopharmaceutical and medical technology companies, IDC Life Sciences Insights, and Transform Pharmaceuticals.

Irena earned an M.S. with Honors in Chemical Engineering from Russian University of Chemical Technology and a Ph.D. in Molecular Medicine/Molecular Biology from the University of Texas.

Irena Melnikova, Ph.D.